Health
7.1
Madagascar HIV cases double in two years, screening gaps mask true scale
Published 15 h ago1 sourceEvidence: Reported
SeverityHighAssessedDeveloping storyLe MondeMG
HealthReportedMedium
5.2
Brazil caps semestral HIV injection at R$20,914; not in SUS
Brazil's health regulator Anvisa set a price ceiling of R$20,914.22 for Sunlenca, a semestral HIV injection, but the drug is not sold in pharmacies nor available in the public health system (SUS). This creates a cost barrier for patients, highlighting access disparities in HIV treatment.
Score Breakdown
Mosaic Score5.2
Model confidence0.7
Significance0.5
Source credibility0.4
Related signals
8 foundHealth
5.2
Brazil's Anvisa seizes counterfeit botulinum toxin batch, bans sale and use
Published 2 d ago1 sourceEvidence: Reported
SeverityModerateAssessedDeveloping storyPoder360BR
Justice
5.2
Brazil STF to Rule on SUS Payment Review Costing R$ 24 Billion
Published 16 h ago1 sourceEvidence: Reported
SeverityModeratePoder360BR
Health
2.0
Brazil SUS expands access to 9 cancer drugs for 116,000 patients
Published 1 d ago1 sourceEvidence: Reported
Poder360BR
Health
2.0
Peru updates HIV/Hep B/C medicine list after 3 years, adds pediatric combo
Published 1 d ago1 sourceEvidence: Reported
La República (Peru)Low-rated sourcePE
Politics
9.4
Brazil 2026 runoff set: Lula vs Bolsonaro, date confirmed
Published 2 d ago11 sourcesEvidence: Reported
SeverityHighAssessedDeveloping storyLa Nación (Argentina)Low-rated sourceBR
Politics
9.2
Brazil runoff: Lula and Flavio Bolsonaro statistically tied with week to go
Published 1 d ago5 sourcesEvidence: Reported
SeverityHighAssessedDeveloping storyDeutsche WelleBR · US
Politics
9.0
Brazil polls: Flávio leads in 12 of 13 surveys, 5 days before election
Published 1 d ago6 sourcesEvidence: Reported
SeverityHighAssessedDeveloping storyPoder360BR